Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: A subgroup analysis of the Van Gogh DVT trial

Frederiek F. van Doormaal; Alexander T. Cohen; Bruce L. Davidson; Herve Decousus; Alexander S. Gallus; Michael Gent; Franco Piovella; Martin H. Prins; Gary E. Raskob; Harry R. Bueller

doi:10.1160/TH09-12-0870

Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: A subgroup analysis of the Van Gogh DVT trial

Frederiek F. van Doormaal, Alexander T. Cohen, Bruce L. Davidson, Herve Decousus, Alexander S. Gallus, Michael Gent, Franco Piovella, Martin H. Prins, Gary E. Raskob, Harry R. Bueller

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	86-91
Journal	Thrombosis and Haemostasis
Volume	104
Issue number	1
DOIs	https://doi.org/10.1160/TH09-12-0870
Publication status	Published - Jul 2010

Keywords

Anticoagulation
cancer
idraparinux
deep venous thrombosis

Access to Document

10.1160/TH09-12-0870

Cite this

van Doormaal, F. F., Cohen, A. T., Davidson, B. L., Decousus, H., Gallus, A. S., Gent, M., Piovella, F., Prins, M. H., Raskob, G. E., & Bueller, H. R. (2010). Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: A subgroup analysis of the Van Gogh DVT trial. Thrombosis and Haemostasis, 104(1), 86-91. https://doi.org/10.1160/TH09-12-0870

van Doormaal, Frederiek F. ; Cohen, Alexander T. ; Davidson, Bruce L. ; Decousus, Herve ; Gallus, Alexander S. ; Gent, Michael ; Piovella, Franco ; Prins, Martin H. ; Raskob, Gary E. ; Bueller, Harry R. / Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: A subgroup analysis of the Van Gogh DVT trial. In: Thrombosis and Haemostasis. 2010 ; Vol. 104, No. 1. pp. 86-91.

@article{cda3fae0713e49a9b265920d7cde5375,

title = "Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: A subgroup analysis of the Van Gogh DVT trial",

keywords = "Anticoagulation, cancer, idraparinux, deep venous thrombosis",

author = "{van Doormaal}, {Frederiek F.} and Cohen, {Alexander T.} and Davidson, {Bruce L.} and Herve Decousus and Gallus, {Alexander S.} and Michael Gent and Franco Piovella and Prins, {Martin H.} and Raskob, {Gary E.} and Bueller, {Harry R.}",

year = "2010",

month = jul,

doi = "10.1160/TH09-12-0870",

language = "English",

volume = "104",

pages = "86--91",

journal = "Thrombosis and Haemostasis",

issn = "0340-6245",

publisher = "Georg Thieme Verlag",

number = "1",

}

van Doormaal, FF, Cohen, AT, Davidson, BL, Decousus, H, Gallus, AS, Gent, M, Piovella, F, Prins, MH, Raskob, GE & Bueller, HR 2010, 'Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: A subgroup analysis of the Van Gogh DVT trial', Thrombosis and Haemostasis, vol. 104, no. 1, pp. 86-91. https://doi.org/10.1160/TH09-12-0870

Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: A subgroup analysis of the Van Gogh DVT trial. / van Doormaal, Frederiek F.; Cohen, Alexander T.; Davidson, Bruce L.; Decousus, Herve; Gallus, Alexander S.; Gent, Michael; Piovella, Franco; Prins, Martin H.; Raskob, Gary E.; Bueller, Harry R.

In: Thrombosis and Haemostasis, Vol. 104, No. 1, 07.2010, p. 86-91.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: A subgroup analysis of the Van Gogh DVT trial

AU - van Doormaal, Frederiek F.

AU - Cohen, Alexander T.

AU - Davidson, Bruce L.

AU - Decousus, Herve

AU - Gallus, Alexander S.

AU - Gent, Michael

AU - Piovella, Franco

AU - Prins, Martin H.

AU - Raskob, Gary E.

AU - Bueller, Harry R.

PY - 2010/7

Y1 - 2010/7

KW - Anticoagulation

KW - cancer

KW - idraparinux

KW - deep venous thrombosis

U2 - 10.1160/TH09-12-0870

DO - 10.1160/TH09-12-0870

M3 - Article

C2 - 20508907

VL - 104

SP - 86

EP - 91

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 1

ER -